HIV antiretroviral drug resistance in Africa.

  title={HIV antiretroviral drug resistance in Africa.},
  author={John N Nkengasong and Christiane A. Adj{\'e}-Tour{\'e} and Paul J. Weidle},
  journal={AIDS reviews},
  volume={6 1},
Highly active antiretroviral therapy (HAART) has dramatically reduced mortality and morbidity in HIV-infected persons in developed countries. Although the use of HAART remains limited in Africa, there are global efforts to make available these drugs to several million HIV-infected persons on the continent. In this review we examine the impact of HIV genetic diversity on the occurrence of drug-resistance mutations among non-B subtypes, and discuss the implication of resistant strains in programs… CONTINUE READING